| 2019 | Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success | 심기남 | Article |
| 2017 | Efficacy of levofloxacin-based third-line therapy for the eradication of helicobacter pylori in peptic ulcer disease | 심기남 | Article |
| 2016 | Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial | 심기남 | Article |
| 2016 | Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial | 심기남 | Article |
| 2022 | Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial | 정혜경; 심기남 | Article |
| 2016 | Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis | 심기남 | Article |
| 2015 | RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma | 정성애; 조민선; 정혜경; 심기남; 김성은 | Article |
| 2017 | Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication | 정성애; 정혜경; 심기남; 김성은; 문창모; 태정현 | Article |
| 2021 | Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection | 정성애; 심기남; 태정현; 송은미; 박예현; 최아름 | Article |
